4//SEC Filing
YOUNG JAMES F 4
Accession 0001209191-22-022544
CIK 0001000694other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:14 PM ET
Size
10.0 KB
Accession
0001209191-22-022544
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
YOUNG JAMES F
Director
Transactions
- Sale
Common Stock
2022-03-31$73.29/sh−8,945$655,550→ 66,145 total - Sale
Common Stock
2022-03-31$74.25/sh−3,255$241,684→ 62,890 total - Sale
Common Stock
2022-03-31$75.10/sh−300$22,531→ 62,590 total
Holdings
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.98 to $73.91, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F2]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F3]The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F4]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001219864
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:14 PM ET
- Size
- 10.0 KB